Partnerships in drug delivery need to fairly reflect the risk all
parties take but there must also be a champion to drive the project
forward, according to Pfizer's director of drug delivery.
SkyePharma used its latest business review meeting to announce the
imminent arrival of a new rheumatoid arthritis (RA) drug formulated
using its novel controlled release drug delivery technology.
A chewing gum to treat Type 2 diabetes and obesity is one step
closer to reality after developers of the technology, Generex,
formed a new partnership with Danish medicinal chewing gum
specialists, Fertin Pharma, to develop the product.
Biotech company Genzyme Pharmaceuticals and drug delivery firm
Brookwood Pharmaceuticals are now working together to create new
ways of delivering peptide-based drugs.
Many said it couldn't be done, but Australian pharma firm
Phosphagenics has developed what it claims is the world's first
transdermal insulin formulation and has received the first signs
that the product may have blockbuster...
Israel's TransPharma has announced the results of the first
clinical trials of human Parathyroid Hormone 1-34 fragment (hPTH
1-34), delivered with its hand-held pen-size transdermal device,
showed its system can systemically...
British company Q Chip has upped the stakes in the drug delivery
market with its new tailor-made bioencapsulation technology,
claiming to improve drug effectiveness, reduce side effects and
increase patient acceptance.
The US advanced drug delivery market will grow more than 18 per
cent and exceed $76 bn (€62 bn) by 2014, spurred on by new
technologies emerging from the biotech and biopharmaceutical
pipelines, according to a new report by Kalorama...
US researchers have managed to create tiny chemical cages that
enclose drugs within a capsule that can be manufactured to deliver
drugs to organs or tissues without causing harm elsewhere.
Australian company pSivida has completed its acquisition of US drug
delivery firm, Control Delivery Systems (CDS), as part of its
strategy to expand its presence in the US biotech industry.
Cardinal Health, the world's largest supplier of services to the
healthcare industry, is building its first tablet coating facility
to offer its pharmaceutical clients a range of innovative delivery
systems that target the oral...
A novel drug delivery system that allows hospital patients to
self-administer pain relief medication without an intravenous line
could be available in the US within six months, pending final Food
and Drug Administration (FDA) approval.
Australian drug delivery company pSivida has inked a deal valued at
$104 million (€87m) to buy Control Delivery Systems of the US,
allowing it tap into the biotechnology hub around Boston on the US
east coast.
UK drug delivery company Phoqus has said it plans to list on the
Alternative Investment Market (AIM) via an institutional placing
that should raise proceeds of £10-£12 million.
The US market for pharmaceutical packaging will grow by nearly a
third between 2004 and 2011, driven by the increasing demands
placed on packaging by biologic drugs and novel drug delivery
formulations, according to consulting firm...
US researchers have developed a nanoparticle-derived shell, which
they believe may some day target tumour cells and deliver
medication to specific locations. The polymer shell protection
ensures the drug can circulate longer without...
US company SurModics is evaluating a biodegradeable polymer
technology, developed at Rutgers University, that could improve the
delivery of drugs into the eye.
A new formulation of the over-the-counter decongestant
pseudoephedrine developed by drug delivery company SCOLR Pharma has
successfully cleared a clinical trial, providing a validation of
the firm's technology platform, reports...
The emergence of nanotechnology is likely to have a significant
impact on drug delivery sector, affecting just about every route of
administration from oral to injectable, according to specialist
market research firm NanoMarkets.
Dow Chemical has signed over its entire portfolio of intellectual
property and technology in the area of dendrimers - branched
polymers with applications in targetted drug delivery - to US firm
Dendritic NanoTechnologies and Starpharma...
A new European project on the emerging discipline of
nanobiotechnology aims to tackle the thorny issue of safety as well
as develop new materials for drug delivery and other medical uses,
reports Phil Taylor.
TransPharma Medical has entered into collaboration with Teva
Pharmaceutical to develop transdermal drug delivery systems. The
deal aims to research and develop transdermal delivery of
therapeutic drugs such as high molecular weight...
West Pharmaceutical Services is to sell a substantial part of its
drug delivery business to a newly formed company in return for $7.1
million (€5.3m) in cash and a 14 per cent stake in the new firm.
OctoPlus, a drug delivery and development company, and InnoCore
Technologies, a supplier of biodegradable polymeric drug delivery
systems, announced a joint collaboration to develop and market a
novel injectable drug delivery platform.
Dutch drug delivery company OctoPlus has licensed two
biodegradeable polymers to SurModics that can be used to coat
medical devices and deliver drugs into the surrounding tissues.
Australian company pSivida is on the brink of starting clinical
trials of a silicon-based nanomaterial that could find broad
applications across drug and vaccine delivery, diagnostics and
tissue engineering, writes Phil Taylor.
Canadian company MIV Therapeutics has been awarded a US patent for
a coating technology for medical devices and drug encapsulation
based on hydroxyapatite, one of the major constituents of bone.
India's Dr Reddy's Laboratories has acquired a US company that
brings in a proprietary drug delivery technology that could be
applied across a whole range of dermatological products.
Access Pharmaceuticals has signed an agreement with an unnamed US
partner for a drug delivery system based on nanoparticle aggregates
that can be used to formulate proteins that are degraded by
solvents.
Researchers in the US have developed a way of self-assembling
liposomes - lipid particles used to carry a drug payload - that are
smaller and more uniform in size than can be achieved using current
methods.
An analysis technology developed by Viscotek can slice days off the
time it takes to carry out research and quality control into drug
delivery systems based on polymers.
Israel-based Biodar, a subsidiary of food ingredient company
Lycored, has announced its acquisition of Karma Pharm in a
transaction that boosts its activities in pharmaceuticals.